220 related articles for article (PubMed ID: 32824687)
41. A feline assay using osteoclasts generated in vitro from peripheral blood for screening anti-resorptive agents.
Muzylak M; Flanagan AM; Ingham K; Gunn N; Price J; Horton MA
Res Vet Sci; 2002 Dec; 73(3):283-90. PubMed ID: 12443687
[TBL] [Abstract][Full Text] [Related]
42. A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.
Panwar P; Søe K; Guido RV; Bueno RV; Delaisse JM; Brömme D
Br J Pharmacol; 2016 Jan; 173(2):396-410. PubMed ID: 26562357
[TBL] [Abstract][Full Text] [Related]
43. Osteoclast function and bone-resorbing activity: An overview.
Soysa NS; Alles N
Biochem Biophys Res Commun; 2016 Jul; 476(3):115-20. PubMed ID: 27157135
[TBL] [Abstract][Full Text] [Related]
44. Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk.
Morita Y; Matsuyama H; Serizawa A; Takeya T; Kawakami H
Bone; 2008 Feb; 42(2):380-7. PubMed ID: 18055286
[TBL] [Abstract][Full Text] [Related]
45. Different cysteine proteinases involved in bone resorption and osteoclast formation.
Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
[TBL] [Abstract][Full Text] [Related]
46. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
47. Investigation of osteoclast cathepsin K activity in osteoclastogenesis and bone loss using a set of chemical reagents.
Janiszewski T; Kołt S; Ciastoń I; Vizovisek M; Poręba M; Turk B; Drąg M; Kozieł J; Kasperkiewicz P
Cell Chem Biol; 2023 Feb; 30(2):159-174.e8. PubMed ID: 36696904
[TBL] [Abstract][Full Text] [Related]
48. Osteoclasts on bone and dentin in vitro: mechanism of trail formation and comparison of resorption behavior.
Rumpler M; Würger T; Roschger P; Zwettler E; Sturmlechner I; Altmann P; Fratzl P; Rogers MJ; Klaushofer K
Calcif Tissue Int; 2013 Dec; 93(6):526-39. PubMed ID: 24022329
[TBL] [Abstract][Full Text] [Related]
49. cAMP-PKA signaling pathway regulates bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts.
Park YG; Kim YH; Kang SK; Kim CH
Int Immunopharmacol; 2006 Jun; 6(6):947-56. PubMed ID: 16644480
[TBL] [Abstract][Full Text] [Related]
50. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
Karsdal MA; Henriksen K; Sørensen MG; Gram J; Schaller S; Dziegiel MH; Heegaard AM; Christophersen P; Martin TJ; Christiansen C; Bollerslev J
Am J Pathol; 2005 Feb; 166(2):467-76. PubMed ID: 15681830
[TBL] [Abstract][Full Text] [Related]
51. Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption.
Yang X; Gandhi C; Rahman MM; Appleford M; Sun LW; Wang X
Calcif Tissue Int; 2015 Dec; 97(6):592-601. PubMed ID: 26204848
[TBL] [Abstract][Full Text] [Related]
52. Centrosome clustering control in osteoclasts through CCR5-mediated signaling.
Lee JW; Lee IH; Watanabe H; Liu Y; Sawada K; Maekawa M; Uehara S; Kobayashi Y; Imai Y; Kong SW; Iimura T
Sci Rep; 2023 Nov; 13(1):20813. PubMed ID: 38012303
[TBL] [Abstract][Full Text] [Related]
53. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
54. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
Löfvall H; Newbould H; Karsdal MA; Dziegiel MH; Richter J; Henriksen K; Thudium CS
Arthritis Res Ther; 2018 Apr; 20(1):67. PubMed ID: 29636095
[TBL] [Abstract][Full Text] [Related]
55. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.
Nakayama T; Mizoguchi T; Uehara S; Yamashita T; Kawahara I; Kobayashi Y; Moriyama Y; Kurihara S; Sahara N; Ozawa H; Udagawa N; Takahashi N
Bone; 2011 Dec; 49(6):1331-9. PubMed ID: 21983021
[TBL] [Abstract][Full Text] [Related]
56. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
[TBL] [Abstract][Full Text] [Related]
57. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44.
Kim SI; Kim YH; Kang BG; Kang MK; Lee EJ; Kim DY; Oh H; Oh SY; Na W; Lim SS; Kang YH
Phytomedicine; 2020 Dec; 79():153351. PubMed ID: 32987362
[TBL] [Abstract][Full Text] [Related]
58. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts.
Fuller K; Lawrence KM; Ross JL; Grabowska UB; Shiroo M; Samuelsson B; Chambers TJ
Bone; 2008 Jan; 42(1):200-11. PubMed ID: 17962093
[TBL] [Abstract][Full Text] [Related]
59. Mineral trioxide aggregate inhibits osteoclastic bone resorption.
Hashiguchi D; Fukushima H; Yasuda H; Masuda W; Tomikawa M; Morikawa K; Maki K; Jimi E
J Dent Res; 2011 Jul; 90(7):912-7. PubMed ID: 21531916
[TBL] [Abstract][Full Text] [Related]
60. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
